• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics Inc (NQ: IOVA )

    10.96 -0.01 (-0.05%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 24,631
    Open 10.96
    Bid (Size) 11.21 (7)
    Ask (Size) 11.24 (18)
    Prev. Close 10.97
    Today's Range 10.96 - 10.96
    52wk Range 3.210 - 18.33
    Shares Outstanding 279,832,722
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The 3 Most Undervalued Biotech Stocks to Buy in May 2024
    Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. 
    Via InvestorPlace
    Why Iovance Stock Is Down 18% Today
    Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue. 
    Via The Motley Fool

    Performance

    YTD
    +35.37%
    +35.37%
    1 Month
    -11.29%
    -11.29%
    3 Month
    +10.20%
    +10.20%
    6 Month
    +172.08%
    +172.08%
    1 Year
    +39.86%
    +39.86%

    More News

    Read More
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    How Is The Market Feeling About Iovance Biotherapeutics?
    Via Benzinga
    Is Iovance Biotherapeutics Stock a Buy Now?
    Via The Motley Fool
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
    Via The Motley Fool
    Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Iovance Biotherapeutics to Present at Upcoming Conferences
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Where Will Iovance Biotherapeutics Stock Be in 5 Years?
    Via The Motley Fool
    The Top 3 Biotech Stocks to Buy in April 2024
    Via InvestorPlace
    3 Millionaire-Maker Biotech Stocks
    Via The Motley Fool
    Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
    Via The Motley Fool
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
    Via MarketBeat
    Topics Cannabis
    Exposures Cannabis
    Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
    Via The Motley Fool
    2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
    Via The Motley Fool
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    7 Biotech Stocks Ready to Ride the Sector’s Resurgence
    Via InvestorPlace
    Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.